This feature is available to journalist, bloggers and other members of the media. You must be logged into ReleaseWire to take advantage of this service.
Posted on Friday, February 17, 2023 at 12:00 pm CST
An investigation on behalf of investors in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) was announced over potential breaches of fiduciary duties by certain officers and directors at Phathom Pharmaceuticals, Inc.
Posted on Friday, February 17, 2023 at 11:45 am CST
An investigation on behalf of current long-term investors in shares of Yatsen Holding Limited (NYSE:YSG) concerning potential breaches of fiduciary duties by certain directors and officers of Yatsen Holding Limited was announced.
Posted on Friday, February 17, 2023 at 11:30 am CST
An investigation on behalf of investors in shares of World Wrestling Entertainment, Inc. (NYSE:WWE) was announced over potential breaches of fiduciary duties by certain officers and directors at World Wrestling Entertainment, Inc.
Posted on Friday, February 17, 2023 at 11:15 am CST
An investor in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) filed a lawsuit against certain directors of Axsome Therapeutics, Inc. over alleged breaches of fiduciary duties.
Posted on Friday, February 17, 2023 at 11:00 am CST
An investigation on behalf of current long-term investors in shares of Schmitt Industries, Inc. (NASDAQ:SMIT) concerning potential breaches of fiduciary duties by certain directors and officers of Schmitt Industries, Inc. was announced.
Posted on Thursday, February 16, 2023 at 12:15 pm CST
An investigation on behalf of investors in shares of Barclays PLC (NYSE:BCS) concerning potential breaches of fiduciary duties by certain directors and officers of Barclays PLC was announced.